10-Q Filing

RELMADA THERAPEUTICS, INC. CIK: 1553643 Q2 2017

Filing Information

Form Type	10-Q
Accession Number	`0001213900-17-001191`
Period End Date	20161231
Filing Date	20170210
Fiscal Year	2017
Fiscal Period	Q2
XBRL Instance	rlmd-20161231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 60 Income Statement 52 Cash Flow Statement 50

Balance Sheet 60 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$22.47M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$15.13M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$8.50M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.71M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$2.35K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	-	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$798.09K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$578.98K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.30M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$9.30M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Fixed assets, net	`PropertyPlantAndEquipmentNet`	$514.87K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	12.04M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	12.04M	shares	Point-in-time
Fixed assets, net	`PropertyPlantAndEquipmentNet`	$531.35K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$414.81K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	12.04M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$414.36K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	12.04M	shares	Point-in-time
Total assets	`Assets`	$6.23M	USD	Point-in-time
Total assets	`Assets`	$10.24M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.26M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$307.24K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$472.48K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$634.85K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$110.03K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$273.67K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$523.50K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$892.50K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.06M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.41M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$137.08K	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$140.91K	USD	Point-in-time
Total liabilities	`Liabilities`	$3.20M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.55M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock value	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock value	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value,100,000,000 shares authorized, 12,035,912 and 12,035,037 shares issued and outstanding, respectively	`CommonStockValue`	$12.04K	USD	Point-in-time
Common stock, $0.001 par value,100,000,000 shares authorized, 12,035,912 and 12,035,037 shares issued and outstanding, respectively	`CommonStockValue`	$12.04K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$86.13M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$86.43M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-81.77M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-79.10M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$4.67M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$7.04M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$10.24M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$6.23M	USD	Point-in-time

Income Statement 52 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$254.10K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$618.26K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.12M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.98M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.28M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$3.60M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$5.37M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$2.53M	USD	2 Qtrs
Total Operating Expenses	`OperatingExpenses`	$3.15M	USD	2 Qtrs
Total Operating Expenses	`OperatingExpenses`	$5.72M	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$1.54M	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$10.35M	USD	2 Qtrs
Loss from Operations	`OperatingIncomeLoss`	$-5.72M	USD	1 Quarter
Loss from Operations	`OperatingIncomeLoss`	$-10.35M	USD	2 Qtrs
Loss from Operations	`OperatingIncomeLoss`	$-1.54M	USD	1 Quarter
Loss from Operations	`OperatingIncomeLoss`	$-3.15M	USD	2 Qtrs
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$12.56M	USD	2 Qtrs
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$449.04K	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$3.26M	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$369.00K	USD	2 Qtrs
Net interest (expense)	`InterestIncomeExpenseNonoperatingNet`	$-1.23K	USD	2 Qtrs
Net interest (expense)	`InterestIncomeExpenseNonoperatingNet`	$-378.00	USD	1 Quarter
Net interest (expense)	`InterestIncomeExpenseNonoperatingNet`	$-927.00	USD	2 Qtrs
Net interest (expense)	`InterestIncomeExpenseNonoperatingNet`	$-329.00	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	$56.91K	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	-	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	$113.82K	USD	2 Qtrs
Other income	`OtherNonoperatingIncome`	-	USD	2 Qtrs
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$505.57K	USD	1 Quarter
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$3.26M	USD	1 Quarter
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$12.55M	USD	2 Qtrs
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$481.59K	USD	2 Qtrs
Net (Loss) Income	`NetIncomeLoss`	$-2.67M	USD	2 Qtrs
Net (Loss) Income	`NetIncomeLoss`	$2.20M	USD	2 Qtrs
Net (Loss) Income	`NetIncomeLoss`	$-1.03M	USD	1 Quarter
Net (Loss) Income	`NetIncomeLoss`	$-2.46M	USD	1 Quarter
Net (Loss) Income per common share - basic	`EarningsPerShareBasic`	$-0.22	USD	2 Qtrs
Net (Loss) Income per common share - basic	`EarningsPerShareBasic`	$-0.09	USD	1 Quarter
Net (Loss) Income per common share - basic	`EarningsPerShareBasic`	$0.20	USD	2 Qtrs
Net (Loss) Income per common share - basic	`EarningsPerShareBasic`	$-0.22	USD	1 Quarter
Net (Loss) Income per common share - diluted	`EarningsPerShareDiluted`	$-0.22	USD	1 Quarter
Net (Loss) Income per common share - diluted	`EarningsPerShareDiluted`	$-0.09	USD	1 Quarter
Net (Loss) Income per common share - diluted	`EarningsPerShareDiluted`	$-0.22	USD	2 Qtrs
Net (Loss) Income per common share - diluted	`EarningsPerShareDiluted`	$0.19	USD	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	11.18M	shares	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	12.04M	shares	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	12.04M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	11.42M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.04M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.04M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	11.86M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	11.42M	shares	1 Quarter

Cash Flow Statement 50 line items

Line Item	Tag	Value	Unit	Period
Net (loss) income	`NetIncomeLoss`	$-2.67M	USD	2 Qtrs
Net (loss) income	`NetIncomeLoss`	$2.20M	USD	2 Qtrs
Net (loss) income	`NetIncomeLoss`	$-1.03M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-2.46M	USD	1 Quarter
Depreciation expense	`Depreciation`	$43.74K	USD	2 Qtrs
Depreciation expense	`Depreciation`	$5.91K	USD	2 Qtrs
Common stock issued for services	`CommonStockIssuedForServices`	-	USD	2 Qtrs
Common stock issued for services	`CommonStockIssuedForServices`	$180.87K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$304.02K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$571.21K	USD	2 Qtrs
Change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$-369.00K	USD	2 Qtrs
Change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$-12.56M	USD	2 Qtrs
Deferred rent liability	`DeferredRentLiability`	$-3.84K	USD	2 Qtrs
Deferred rent liability	`DeferredRentLiability`	$54.83K	USD	2 Qtrs
Prepaid expenses, other current assets and other assets	`IncreaseDecreaseInPrepaidExpensesOther`	$-957.81K	USD	2 Qtrs
Prepaid expenses, other current assets and other assets	`IncreaseDecreaseInPrepaidExpensesOther`	$-216.31K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$810.80K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-952.48K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-162.37K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$1.08M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.60M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-6.69M	USD	2 Qtrs
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	$476.11K	USD	2 Qtrs
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	$27.26K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-476.11K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-27.26K	USD	2 Qtrs
Principal payments of note payable	`RepaymentsOfNotesPayable`	$163.64K	USD	2 Qtrs
Principal payments of note payable	`RepaymentsOfNotesPayable`	$175.22K	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-175.22K	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-163.64K	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-7.34M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-3.79M	USD	2 Qtrs
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$22.47M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$15.13M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$8.50M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$4.71M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$22.47M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$15.13M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$8.50M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$4.71M	USD	Point-in-time
Income taxes	`IncomeTaxesPaidNet`	-	USD	2 Qtrs
Income taxes	`IncomeTaxesPaidNet`	-	USD	2 Qtrs
Interest	`InterestPaid`	$2.81K	USD	2 Qtrs
Interest	`InterestPaid`	$2.23K	USD	2 Qtrs
Payable incurred for purchases of fixed assets	`PayableIncurredForPurchasesOfFixedAssets`	$41.63K	USD	2 Qtrs
Payable incurred for purchases of fixed assets	`PayableIncurredForPurchasesOfFixedAssets`	-	USD	2 Qtrs
Conversion of Class A convertible preferred stock to common stock	`ConversionOfStockAmountConverted1`	-	USD	2 Qtrs
Conversion of Class A convertible preferred stock to common stock	`ConversionOfStockAmountConverted1`	$72.00	USD	2 Qtrs
Issuances of common stock resulting from cashless exercise of warrants	`StockIssued1`	$1.09K	USD	2 Qtrs
Issuances of common stock resulting from cashless exercise of warrants	`StockIssued1`	-	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.